Bernard William Downs (Bill W Downs, William B Downs, Bernard W Downs, B William Downs)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 17

Top Topics

Alcohol Use Disorder

Intimate Partner Violence

Prefrontal Cortex

Top Venues

Journal of personalized medicine

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Anish Bajaj, Kenneth Blum, Abdalla Bowirrat, Ashim Gupta, David Baron, David Fugel, Ayo Nicholson, Taylor Fitch, Bernard William Downs, Debasis Bagchi, Catherine A Dennen, Rajendra D Badgaiyan
DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave ® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of "Dopamine Homeostasis" in the Face of the Opioid Crisis. Journal of personalized medicine 12 (9) (2022)
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, Catherine A Dennen, Eric R Braverman, David Baron, Thomas Mclaughlin, John Giordano, Ashim Gupta, Bernard William Downs, Debasis Bagchi, Debmalya Barh, Igor Elman, Panayotis K Thanos, Rajendra D Badgaiyan, Drew Edwards, Mark S Gold
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of personalized medicine 12 (12) (2022)
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, Catherine A Dennen, Eric R Braverman, David Baron, Thomas Mclaughlin, John Giordano, Ashim Gupta, Bernard William Downs, Debasis Bagchi, Debmalya Barh, Igor Elman, Panayotis K Thanos, Rajendra D Badgaiyan, Drew Edwards, Mark S Gold
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of personalized medicine 12 (12) (2022)
Edward Justin Modestino, Kenneth Blum, Catherine A Dennen, Bernard William Downs, Debasis Bagchi, Luis Llanos-Gomez, Igor Elman, David Baron, Panayotis K Thanos, Rajendra D Badgaiyan, Eric R Braverman, Ashim Gupta, Mark S Gold, Abdalla Bowirrat
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of personalized medicine 12 (12) (2022)
Kenneth Blum, David Han, Abdalla Bowirrat, Bernard William Downs, Debasis Bagchi, Panayotis K Thanos, David Baron, Eric R Braverman, Catherine A Dennen, Ashim Gupta, Igor Elman, Rajendra D Badgaiyan, Luis Llanos-Gomez, Jag H Khalsa, Debmalya Barh, Thomas McLaughlin, Mark S Gold
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index. Journal of personalized medicine 12 (11) (2022)
Kenneth Blum, David Han, Abdalla Bowirrat, Bernard William Downs, Debasis Bagchi, Panayotis K Thanos, David Baron, Eric R Braverman, Catherine A Dennen, Ashim Gupta, Igor Elman, Rajendra D Badgaiyan, Luis Llanos-Gomez, Jag H Khalsa, Debmalya Barh, Thomas McLaughlin, Mark S Gold
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index. Journal of personalized medicine 12 (11) (2022)
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, Catherine A Dennen, Eric R Braverman, David Baron, Thomas Mclaughlin, John Giordano, Ashim Gupta, Bernard William Downs, Debasis Bagchi, Debmalya Barh, Igor Elman, Panayotis K Thanos, Rajendra D Badgaiyan, Drew Edwards, Mark S Gold
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of personalized medicine 12 (12) (2022)
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, Catherine A Dennen, Eric R Braverman, David Baron, Thomas Mclaughlin, John Giordano, Ashim Gupta, Bernard William Downs, Debasis Bagchi, Debmalya Barh, Igor Elman, Panayotis K Thanos, Rajendra D Badgaiyan, Drew Edwards, Mark S Gold
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of personalized medicine 12 (12) (2022)
Kenneth Blum, David Han, Ashim Gupta, David Baron, Eric R Braverman, Catherine A Dennen, Shan Kazmi, Luis Llanos-Gomez, Rajendra D Badgaiyan, Igor Elman, Panayotis K Thanos, Bernard William Downs, Debasis Bagchi, Marjorie C Gondre-Lewis, Mark S Gold, Abdalla Bowirrat
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control Subjects. Journal of personalized medicine 12 (9) (2022)
Kenneth Blum, Catherine A Dennen, Igor Elman, Abdalla Bowirrat, Panayotis K Thanos, Rajendra D Badgaiyan, Bernard William Downs, Debasis Bagchi, David Baron, Eric R Braverman, Ashim Gupta, Richard Green, Thomas McLaughlin, Debmalya Barh, Mark S Gold
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry? Journal of personalized medicine 12 (10) (2022)
Edward Justin Modestino, Kenneth Blum, Catherine A Dennen, Bernard William Downs, Debasis Bagchi, Luis Llanos-Gomez, Igor Elman, David Baron, Panayotis K Thanos, Rajendra D Badgaiyan, Eric R Braverman, Ashim Gupta, Mark S Gold, Abdalla Bowirrat
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of personalized medicine 12 (12) (2022)
Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, Igor Elman, Mauro Ceccanti, Rajendra D Badgaiyan, Thomas McLaughlin, Ashim Gupta, Anish Bajaj, David Baron, Bernard William Downs, Debasis Bagchi, Mark S Gold
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. Journal of personalized medicine 12 (11) (2022)
Edward Justin Modestino, Kenneth Blum, Catherine A Dennen, Bernard William Downs, Debasis Bagchi, Luis Llanos-Gomez, Igor Elman, David Baron, Panayotis K Thanos, Rajendra D Badgaiyan, Eric R Braverman, Ashim Gupta, Mark S Gold, Abdalla Bowirrat
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of personalized medicine 12 (12) (2022)
Edward Justin Modestino, Kenneth Blum, Catherine A Dennen, Bernard William Downs, Debasis Bagchi, Luis Llanos-Gomez, Igor Elman, David Baron, Panayotis K Thanos, Rajendra D Badgaiyan, Eric R Braverman, Ashim Gupta, Mark S Gold, Abdalla Bowirrat
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of personalized medicine 12 (12) (2022)
Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, Igor Elman, Mauro Ceccanti, Rajendra D Badgaiyan, Thomas McLaughlin, Ashim Gupta, Anish Bajaj, David Baron, Bernard William Downs, Debasis Bagchi, Mark S Gold
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. Journal of personalized medicine 12 (11) (2022)
Kenneth Blum, Abdalla Bowirrat, Eric R Braverman, David Baron, Jean-Lud Cadet, Shan Kazmi, Igor Elman, Panyotis K Thanos, Rajendra D Badgaiyan, Bernard William Downs, Debasis Bagchi, Luis Llanos-Gomez, Mark S Gold
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. International journal of environmental research and public health 18 (21) (2021)
Kenneth Blum, Mark S Gold, Luis Llanos-Gomez, Rehan Jalali, Panayotis K Thanos, Abdalla Bowirrat, Bernard William Downs, Debasis Bagchi, Eric R Braverman, David Baron, Alphonso Kenison Roy, Rajendra D Badgaiyan
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction? International journal of environmental research and public health 18 (18) (2021)